Accelerated leukemogenesis by truncated CBFβ-SMMHC defective in high-affinity binding with RUNX1

Dominant RUNX1 inhibition has been proposed as a common pathway for CBF-leukemia. CBFβ-SMMHC, a fusion protein in human acute myeloid leukemia (AML), dominantly inhibits RUNX1 largely through its RUNX1 high-affinity binding domain (HABD). However, the type I CBFβ-SMMHC fusion in AML patients lacks H...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kamikubo, Yasuhiko, Zhao, Ling, Wunderlich, Mark, Corpora, Takeshi, Hyde, R. Katherine, Paul, Thomas A., Kundu, Mondira, Garrett, Lisa, Compton, Sheila, Huang, Gang, Wolff, Linda, Ito, Yoshiaki, Bushweller, John, Mulloy, James C., Liu, P. Paul
פורמט: Artigo
שפה:Inglês
יצא לאור: 2010
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874204/
https://ncbi.nlm.nih.gov/pubmed/20478528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2010.03.022
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים